Literature DB >> 3006861

Cholinergic approaches to the treatment of Alzheimer's disease.

E Hollander, R C Mohs, K L Davis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3006861     DOI: 10.1093/oxfordjournals.bmb.a072106

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


× No keyword cloud information.
  16 in total

1.  The utility of muscarinic agonists in the treatment of Alzheimer's disease.

Authors:  William S Messer
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

Review 2.  Glucocorticoids in Alzheimer's disease. The story so far.

Authors:  P S Aisen; G M Pasinetti
Journal:  Drugs Aging       Date:  1998-01       Impact factor: 3.923

Review 3.  Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia.

Authors:  C D Nicholson
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Physostigmine restores 3H-acetylcholine efflux from Alzheimer brain slices to normal level.

Authors:  L Nilsson; A Nordberg; J Hardy; P Wester; B Winblad
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

5.  Physiologically based pharmacokinetic modeling of SNU-0039, an anti-Alzheimer's agent, in rats.

Authors:  Kyeong-Ryoon Lee; Yoon-Jee Chae; Han-Joo Maeng; Jeewoo Lee; Dae-Duk Kim; Saeho Chong; Chang-Koo Shim; Suk-Jae Chung
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-08-25       Impact factor: 2.745

6.  Synthesis of Novel 3-Aryl-N-Methyl-1,2,5,6-Tetrahydropyridine Derivatives by Suzuki coupling: As Acetyl Cholinesterase Inhibitors.

Authors:  S B Benaka Prasad; Y C Sunil Kumar; C S Ananda Kumar; C T Sadashiva; K Vinaya; K S Rangappa
Journal:  Open Med Chem J       Date:  2007-09-05

7.  Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: double blind trial.

Authors:  N Maltby; G A Broe; H Creasey; A F Jorm; H Christensen; W S Brooks
Journal:  BMJ       Date:  1994-04-02

8.  Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brains via nicotinic receptors?

Authors:  L Nilsson; A Adem; J Hardy; B Winblad; A Nordberg
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

9.  Reversal effect of DM-9384 on scopolamine-induced acetylcholine depletion in certain regions of the mouse brain.

Authors:  E Abe
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

10.  L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors.

Authors:  R J Hargreaves; A T McKnight; K Scholey; N R Newberry; L J Street; P H Hutson; J E Semark; E A Harley; S Patel; S B Freedman
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.